OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 97 filers reported holding OLEMA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,405,002 | -7.7% | 437,652 | -32.5% | 1.05% | +7.9% |
| Q2 2023 | $5,854,628 | +69.4% | 648,353 | -34.9% | 0.98% | +47.0% |
| Q1 2023 | $3,455,804 | -2.2% | 995,909 | -30.9% | 0.66% | -2.9% |
| Q4 2022 | $3,532,422 | +44.9% | 1,441,805 | +63.3% | 0.68% | +42.5% |
| Q3 2022 | $2,437,000 | -73.9% | 883,056 | +161.0% | 0.48% | -38.1% |
| Q3 2021 | $9,326,000 | -32.0% | 338,381 | -30.9% | 0.78% | -30.0% |
| Q2 2021 | $13,711,000 | +3103.5% | 490,020 | +3698.6% | 1.11% | +3365.6% |
| Q1 2021 | $428,000 | – | 12,900 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 3,743,875 | $15,238,000 | 2.80% |
| Fairmount Funds Management LLC | 2,669,300 | $10,864,000 | 2.49% |
| BVF INC/IL | 7,611,503 | $30,979,000 | 1.50% |
| Vivo Capital, LLC | 1,689,515 | $6,876,000 | 0.69% |
| Cormorant Asset Management, LP | 2,082,000 | $8,474,000 | 0.64% |
| Newtyn Management, LLC | 500,000 | $2,035,000 | 0.39% |
| Kynam Capital Management, LP | 249,229 | $1,014,000 | 0.26% |
| Monaco Asset Management SAM | 130,000 | $529,000 | 0.23% |
| TANG CAPITAL MANAGEMENT LLC | 318,926 | $1,298,000 | 0.20% |
| Artal Group S.A. | 260,500 | $1,060,000 | 0.06% |